Bharat Biotech launches swine flu vaccine

Bharat Biotech has launched an indigenously developed cell culture H1N1 swine flu vaccine under the brand name HNVAC. It is the only vaccine to be manufactured in cell culture in a highly sterile and controlled manufacturing process, instead of eggs, claims the company. Krishna Ella, CMD, said that HNVAC was tested extensively in one of the largest phase I, II and III clinical trials for flu vaccines in the country and has proved that it is safe and well tolerated.